Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA
Processa Pharmaceuticals Announces PCS12852 Successfully Improves the Clinical Symptoms Associated with Gastroparesis in Phase 2A Trial
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA
Processa Pharmaceuticals Announces Third Quarter Financial Results and Provides Corporate Update
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA
PCS12852 Improves Gastric Emptying in Gastroparesis Patients
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA
Processa Pharmaceuticals to Host Conference Call to Discuss Third Quarter 2022 Results and Provide Drug Development Update on November 8, 2022 at 4:30 p.m. EST
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA
Processa Successfully Identifies Next Generation Capecitabine Dosage Regimens for Phase 2B Trial
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers PCSA
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.